ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,848,610 | +157.3% | 8,299,808 | +191.5% | 0.07% | +37.5% |
Q2 2023 | $6,547,930 | -59.6% | 2,846,926 | -46.8% | 0.05% | -32.4% |
Q1 2023 | $16,204,295 | +43.4% | 5,347,952 | +10.2% | 0.07% | -38.8% |
Q4 2022 | $11,303,799 | +19.3% | 4,851,416 | -2.2% | 0.12% | +38.1% |
Q3 2022 | $9,477,000 | -25.1% | 4,961,895 | +6.3% | 0.08% | -12.5% |
Q2 2022 | $12,651,000 | -5.3% | 4,668,227 | +4.1% | 0.10% | -47.0% |
Q1 2022 | $13,360,000 | +90.2% | 4,483,327 | +148.3% | 0.18% | +154.9% |
Q4 2021 | $7,024,000 | -9.0% | 1,805,700 | +0.3% | 0.07% | -32.4% |
Q3 2021 | $7,722,000 | +41.6% | 1,800,000 | 0.0% | 0.10% | +59.1% |
Q2 2021 | $5,454,000 | +17.0% | 1,800,000 | +28.6% | 0.07% | +15.8% |
Q1 2021 | $4,662,000 | -9.4% | 1,400,000 | -3.4% | 0.06% | +103.6% |
Q4 2020 | $5,148,000 | +131.7% | 1,450,000 | +104.2% | 0.03% | -15.2% |
Q3 2020 | $2,222,000 | +25.3% | 710,000 | -27.2% | 0.03% | +6.5% |
Q2 2020 | $1,774,000 | +119.6% | 975,000 | +21.9% | 0.03% | +55.0% |
Q1 2020 | $808,000 | -65.8% | 800,000 | -5.9% | 0.02% | -62.3% |
Q4 2019 | $2,363,000 | +73.1% | 850,000 | -5.0% | 0.05% | +39.5% |
Q3 2019 | $1,365,000 | -25.9% | 895,000 | +1.1% | 0.04% | -9.5% |
Q2 2019 | $1,841,000 | -20.9% | 885,000 | +36.2% | 0.04% | +40.0% |
Q1 2019 | $2,327,000 | -6.5% | 650,000 | 0.0% | 0.03% | -9.1% |
Q4 2018 | $2,490,000 | +75.6% | 650,000 | +333.3% | 0.03% | +83.3% |
Q3 2018 | $1,418,000 | +5.0% | 150,000 | -18.9% | 0.02% | -5.3% |
Q2 2018 | $1,351,000 | -24.9% | 185,000 | -48.6% | 0.02% | -48.6% |
Q1 2018 | $1,800,000 | -10.9% | 360,000 | -10.0% | 0.04% | -14.0% |
Q4 2017 | $2,020,000 | +176.0% | 400,000 | +239.0% | 0.04% | +138.9% |
Q3 2017 | $732,000 | -31.1% | 118,000 | -60.0% | 0.02% | -14.3% |
Q2 2017 | $1,062,000 | +26.7% | 295,000 | +14.3% | 0.02% | +90.9% |
Q1 2017 | $838,000 | – | 257,988 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
Kepos Capital LP | 200,000 | $778,000 | 0.06% |
XTX Topco Ltd | 29,026 | $113,000 | 0.06% |